APOE2 allele increased in tardive dyskinesia

Movement Disorders

Volumn 21, Issue 4, 2006, Pages 540-542

  Halford, Jonathan ^a,b   Mazeika, Gandis ^a,c   Slifer, Susan ^a   Speer, Marcy ^a   Saunders, Ann M ^a,d   Strittmatter, Warren J ^a   Morgenlander, Joel C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Sleep Medicine Northwest   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Apolipoprotein E; Tardive dyskinesia

Indexed keywords

APOLIPOPROTEIN E2; NEUROLEPTIC AGENT;

AFRICAN AMERICAN; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DRUG COST; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOME ANALYSIS; GENOTYPE; HEREDITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SCORING SYSTEM; SEQUENCE ANALYSIS; TARDIVE DYSKINESIA;

AFRICAN CONTINENTAL ANCESTRY GROUP; AKATHISIA, DRUG-INDUCED; ALLELES; APOLIPOPROTEIN E2; APOLIPOPROTEINS E; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; RISK; SCHIZOPHRENIA;

EID: 33646249132     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20768     Document Type: Article

References (10)

1. Yassa R, Ananth J. Familial tardive dyskinesia. Am J Psychiatry 1981;138:1618-1619.
2. Rosengarten H, Schweitzer JW, Friedhoff AJ. Possible genetic factors underlying the pathophysiology of tardive dyskinesia. Pharmacol Biochem Behav 1994;49:663-667.
3. Raber J. Androgens, apo E, and Alzheimer's disease. Sci Aging Knowledge Environ 2004;11:re2.
4. Farrer LA, Cupples LA, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349-1356.
5. Huang X, Chen PC, Poole C. APOE-∈2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 2004; 62:2198-2002.
6. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-548.
7. Harrington CR, Roth M, Xuereb JH et al. Apolipoprotein E type e4 allele frequency is increased in patients with schizophrenia. Neurosci Lett 1995;202:101-104.
8. Sorbi S, Nacmias B, Tedde A, et al. No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. Neurosci Lett 1998;244:118-120.
9. Pahl JJ, Mazziota JC, Bartzokis G, et al. Positron-emission tomography in tardive dyskinesia. J Neuropsychiatry Clin Neurosci 1995; 7:457-465.
10. Rall SC, Weisgraber KH, Innerarity TL, et al. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo- and hypercholesterolemic dysbetalipoproteinemia. J Clin Invest 1983;71:1023-1031.